• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1 型糖尿病的风险因素,包括环境、行为和肠道微生物因素:一项病例对照研究。

Risk factors for type 1 diabetes, including environmental, behavioural and gut microbial factors: a case-control study.

机构信息

Department of Public Health and Pediatrics, University of Turin, Piazza Polonia 94, 10126, Torino, Italy.

Department of Public Health and Pediatrics, Hygiene Unit, University of the Study of Turin, via Santena 5 bis, 10126, Torino, Italy.

出版信息

Sci Rep. 2020 Oct 16;10(1):17566. doi: 10.1038/s41598-020-74678-6.

DOI:10.1038/s41598-020-74678-6
PMID:33067559
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7568546/
Abstract

Type 1 diabetes (T1D) is a common autoimmune disease that is characterized by insufficient insulin production. The onset of T1D is the result of gene-environment interactions. Sociodemographic and behavioural factors may contribute to T1D, and the gut microbiota is proposed to be a driving factor of T1D. An integrated preventive strategy for T1D is not available at present. This case-control study attempted to estimate the exposure linked to T1D to identify significant risk factors for healthy children. Forty children with T1D and 56 healthy controls were included in this study. Anthropometric, socio-economic, nutritional, behavioural, and clinical data were collected. Faecal bacteria were investigated by molecular methods. The findings showed, in multivariable model, that the risk factors for T1D include higher Firmicutes levels (OR 7.30; IC 2.26-23.54) and higher carbohydrate intake (OR 1.03; IC 1.01-1.05), whereas having a greater amount of Bifidobacterium in the gut (OR 0.13; IC 0.05 - 0.34) was a protective factor for T1D. These findings may facilitate the development of preventive strategies for T1D, such as performing genetic screening, characterizing the gut microbiota, and managing nutritional and social factors.

摘要

1 型糖尿病(T1D)是一种常见的自身免疫性疾病,其特征是胰岛素分泌不足。T1D 的发病是基因-环境相互作用的结果。社会人口统计学和行为因素可能导致 T1D,而肠道微生物群被认为是 T1D 的驱动因素。目前还没有针对 T1D 的综合预防策略。本病例对照研究试图估计与 T1D 相关的暴露情况,以确定健康儿童的显著危险因素。本研究纳入了 40 名 T1D 患儿和 56 名健康对照。收集了人体测量、社会经济、营养、行为和临床数据。采用分子方法研究粪便细菌。研究结果表明,在多变量模型中,T1D 的危险因素包括更高的厚壁菌门水平(OR 7.30;95%CI 2.26-23.54)和更高的碳水化合物摄入量(OR 1.03;95%CI 1.01-1.05),而肠道中双歧杆菌数量较多(OR 0.13;95%CI 0.05-0.34)是 T1D 的保护因素。这些发现可能有助于制定 T1D 的预防策略,例如进行遗传筛查、描述肠道微生物群,并管理营养和社会因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa3/7568546/4f962f8cc637/41598_2020_74678_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa3/7568546/102f430c78b2/41598_2020_74678_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa3/7568546/4f962f8cc637/41598_2020_74678_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa3/7568546/102f430c78b2/41598_2020_74678_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa3/7568546/4f962f8cc637/41598_2020_74678_Fig2_HTML.jpg

相似文献

1
Risk factors for type 1 diabetes, including environmental, behavioural and gut microbial factors: a case-control study.1 型糖尿病的风险因素,包括环境、行为和肠道微生物因素:一项病例对照研究。
Sci Rep. 2020 Oct 16;10(1):17566. doi: 10.1038/s41598-020-74678-6.
2
The human gut microbiome in early-onset type 1 diabetes from the TEDDY study.TEDDY 研究中的早发性 1 型糖尿病患者的人类肠道微生物组。
Nature. 2018 Oct;562(7728):589-594. doi: 10.1038/s41586-018-0620-2. Epub 2018 Oct 24.
3
Impact of type 1 diabetes on the composition and functional potential of gut microbiome in children and adolescents: possible mechanisms, current knowledge, and challenges.1 型糖尿病对儿童和青少年肠道微生物组组成和功能潜力的影响:可能的机制、现有知识和挑战。
Gut Microbes. 2021 Jan-Dec;13(1):1-18. doi: 10.1080/19490976.2021.1926841.
4
The bacteriome at the onset of type 1 diabetes: A study from four geographically distant African and Asian countries.1 型糖尿病发病时的细菌组:来自四个地理位置不同的非洲和亚洲国家的研究。
Diabetes Res Clin Pract. 2018 Oct;144:51-62. doi: 10.1016/j.diabres.2018.08.010. Epub 2018 Aug 16.
5
Is there a role for gut microbiota in type 1 diabetes pathogenesis?肠道微生物群在1型糖尿病发病机制中起作用吗?
Ann Med. 2017 Feb;49(1):11-22. doi: 10.1080/07853890.2016.1222449. Epub 2016 Nov 29.
6
Association between intestinal permeability and faecal microbiota composition in Italian children with beta cell autoimmunity at risk for type 1 diabetes.1型糖尿病风险的意大利β细胞自身免疫性儿童肠道通透性与粪便微生物群组成之间的关联。
Diabetes Metab Res Rev. 2016 Oct;32(7):700-709. doi: 10.1002/dmrr.2790. Epub 2016 Mar 30.
7
Gut Microbiota Profile in Patients with Type 1 Diabetes Based on 16S rRNA Gene Sequencing: A Systematic Review.基于 16S rRNA 基因测序的 1 型糖尿病患者肠道微生物群特征:系统评价。
Dis Markers. 2020 Aug 27;2020:3936247. doi: 10.1155/2020/3936247. eCollection 2020.
8
Fecal microbiota imbalance in Mexican children with type 1 diabetes.墨西哥1型糖尿病儿童的粪便微生物群失衡
Sci Rep. 2014 Jan 22;4:3814. doi: 10.1038/srep03814.
9
Gut Microbiota and Type 1 Diabetes.肠道微生物群与 1 型糖尿病。
Int J Mol Sci. 2018 Mar 27;19(4):995. doi: 10.3390/ijms19040995.
10
Associations between diet, the gut microbiome and short chain fatty acids in youth with islet autoimmunity and type 1 diabetes.饮食、肠道微生物群和短链脂肪酸在具有胰岛自身免疫和 1 型糖尿病的青少年中的相关性。
Pediatr Diabetes. 2021 May;22(3):425-433. doi: 10.1111/pedi.13178. Epub 2021 Feb 1.

引用本文的文献

1
The impact of three months of adjuvant yoga intervention on glycemic control among adolescents with type 1 diabetes: a randomized control trial.为期三个月的辅助瑜伽干预对1型糖尿病青少年血糖控制的影响:一项随机对照试验。
Diabetol Metab Syndr. 2025 Jun 16;17(1):216. doi: 10.1186/s13098-025-01632-9.
2
Microbiome and pediatric leukemia, diabetes, and allergies: Systematic review and meta-analysis.微生物组与小儿白血病、糖尿病和过敏:系统评价与荟萃分析。
PLoS One. 2025 May 20;20(5):e0324167. doi: 10.1371/journal.pone.0324167. eCollection 2025.
3
From Microbes to Metabolites: Advances in Gut Microbiome Research in Type 1 Diabetes.

本文引用的文献

1
Microbiota, epidemiological and nutritional factors related to ketoacidosis at the onset of type 1 diabetes.与 1 型糖尿病发病时酮症酸中毒相关的微生物群、流行病学和营养因素。
Acta Diabetol. 2020 Nov;57(11):1337-1349. doi: 10.1007/s00592-020-01555-z. Epub 2020 Jun 27.
2
The heterogeneous pathogenesis of type 1 diabetes mellitus.1 型糖尿病的异质性发病机制。
Nat Rev Endocrinol. 2019 Nov;15(11):635-650. doi: 10.1038/s41574-019-0254-y. Epub 2019 Sep 18.
3
Characteristics of familial type 1 diabetes: effects of the relationship to the affected family member on phenotype and genotype at diagnosis.
从微生物到代谢产物:1型糖尿病肠道微生物组研究进展
Metabolites. 2025 Feb 19;15(2):138. doi: 10.3390/metabo15020138.
4
Investigating the Role of Gut Microbiota in Pediatric Patients with Severe COVID-19 or MIS-C.探究肠道微生物群在患有重症COVID-19或儿童多系统炎症综合征的儿科患者中的作用。
Microorganisms. 2025 Jan 4;13(1):83. doi: 10.3390/microorganisms13010083.
5
Insights in Nutrition to Optimize Type 1 Diabetes Therapy.营养新视角助力优化 1 型糖尿病治疗。
Nutrients. 2024 Oct 26;16(21):3639. doi: 10.3390/nu16213639.
6
Association between type 1 diabetes mellitus and ankylosing spondylitis: a two-sample Mendelian randomization study.1 型糖尿病与强直性脊柱炎的相关性:两样本 Mendelian 随机研究。
Front Immunol. 2023 Dec 20;14:1289104. doi: 10.3389/fimmu.2023.1289104. eCollection 2023.
7
How do parasitic worms prevent diabetes? An exploration of their influence on macrophage and β-cell crosstalk.寄生虫如何预防糖尿病?探究其对巨噬细胞和β细胞串扰的影响。
Front Endocrinol (Lausanne). 2023 Jul 26;14:1205219. doi: 10.3389/fendo.2023.1205219. eCollection 2023.
8
Type 1 : A Review on Advances and Challenges in Creating Insulin Producing Devices.类型1:关于制造胰岛素生产设备的进展与挑战的综述
Micromachines (Basel). 2023 Jan 6;14(1):151. doi: 10.3390/mi14010151.
9
Gut microbiota, behavior, and nutrition after type 1 diabetes diagnosis: A longitudinal study for supporting data in the metabolic control.1型糖尿病诊断后的肠道微生物群、行为和营养:一项支持代谢控制数据的纵向研究。
Front Nutr. 2022 Dec 6;9:968068. doi: 10.3389/fnut.2022.968068. eCollection 2022.
10
Vitamin D and ω-3 Polyunsaturated Fatty Acids towards a Personalized Nutrition of Youth Diabetes: A Narrative Lecture.维生素 D 和 ω-3 多不饱和脂肪酸:青少年糖尿病的个性化营养——叙事讲座。
Nutrients. 2022 Nov 18;14(22):4887. doi: 10.3390/nu14224887.
家族性 1 型糖尿病的特征:与受影响家庭成员关系对诊断时表型和基因型的影响。
Diabetologia. 2019 Nov;62(11):2025-2039. doi: 10.1007/s00125-019-4952-8. Epub 2019 Jul 25.
4
The remission phase in type 1 diabetes: Changing epidemiology, definitions, and emerging immuno-metabolic mechanisms.1 型糖尿病缓解期:不断变化的流行病学、定义和新出现的免疫代谢机制。
Diabetes Metab Res Rev. 2020 Feb;36(2):e3207. doi: 10.1002/dmrr.3207. Epub 2019 Aug 13.
5
Microbiome and type 1 diabetes.肠道微生物群与 1 型糖尿病。
EBioMedicine. 2019 Aug;46:512-521. doi: 10.1016/j.ebiom.2019.06.031. Epub 2019 Jun 27.
6
Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials-GPPAD-02 study design and first results.为将患 1 型糖尿病风险较高的婴儿纳入原发性预防试验(GPPAD-02 研究)而进行的婴儿鉴定-研究设计和初步结果。
Pediatr Diabetes. 2019 Sep;20(6):720-727. doi: 10.1111/pedi.12870. Epub 2019 Jun 13.
7
Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: A prospective cohort study.肠道微生物组失调和儿童胰岛自身免疫和 1 型糖尿病中肠通透性增加:一项前瞻性队列研究。
Pediatr Diabetes. 2019 Aug;20(5):574-583. doi: 10.1111/pedi.12865. Epub 2019 May 20.
8
Screening for asymptomatic β-cell autoimmunity in young children.幼儿无症状β细胞自身免疫的筛查
Lancet Child Adolesc Health. 2019 May;3(5):288-290. doi: 10.1016/S2352-4642(19)30028-8. Epub 2019 Feb 10.
9
Temporal development of the gut microbiome in early childhood from the TEDDY study.婴幼儿时期肠道微生物组的时间发展:来自 TEDDY 研究。
Nature. 2018 Oct;562(7728):583-588. doi: 10.1038/s41586-018-0617-x. Epub 2018 Oct 24.
10
The human gut microbiome in early-onset type 1 diabetes from the TEDDY study.TEDDY 研究中的早发性 1 型糖尿病患者的人类肠道微生物组。
Nature. 2018 Oct;562(7728):589-594. doi: 10.1038/s41586-018-0620-2. Epub 2018 Oct 24.